Gs/Gq signaling switch in β cells defines incretin effectiveness in diabetes

Okechi S. Oduori(Kobe University), Susumu Seino(Kobe University), Quan Zhang(Churchill Hospital), Naoya Murao(Helmholtz Zentrum München), Takashi Miki(Chiba University), Claudia Guida, Kenju Shimomura(Centre for Human Genetics), Shihomi Sakai(Kobe University), Harumi Takahashi(Kobe University), Belén Chanclón(University of Gothenburg), Norihide Yokoi(Kyoto University), Johan Tolö(Universitätsmedizin Göttingen), Patrik Rorsman(Churchill Hospital), Yuko Maejima(Jichi Medical University), Kohtaro Minami(Kobe University), Yasuhiro Minami(University of Electro-Communications), Haiqiang Dou(University of Gothenburg), Lakshmi Kothegala(Churchill Hospital)
Journal of Clinical Investigation
November 15, 2020
Cited by 103


Related Papers